Editorial comment.
作者信息
Akhtar Naveed H, Tagawa Scott T
出版信息
J Urol. 2011 Jan;185(1):59. doi: 10.1016/j.juro.2010.09.134. Epub 2010 Nov 12.
PMID:21074812
Abstract
摘要
相似文献
1
Editorial comment.
J Urol. 2011 Jan;185(1):59. doi: 10.1016/j.juro.2010.09.134. Epub 2010 Nov 12.
2
Editorial comment.
J Urol. 2011 Jan;185(1):66. doi: 10.1016/j.juro.2010.09.138. Epub 2010 Nov 12.
3
The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
J Urol. 2011 Jan;185(1):54-9. doi: 10.1016/j.juro.2010.09.018. Epub 2010 Nov 12.
4
Cytoreductive nephrectomy for metastatic renal cell carcinoma.
J Urol. 2013 Aug;190(2):386-8. doi: 10.1016/j.juro.2013.05.029. Epub 2013 May 21.
5
For: Radical nephrectomy in the setting of metastatic renal cell cancer: proceed judiciously.
J Urol. 2009 Sep;182(3):832-3. doi: 10.1016/j.juro.2009.06.076.
6
Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma.
J Urol. 2009 Sep;182(3):833-4. doi: 10.1016/j.juro.2009.06.077. Epub 2009 Jul 18.
7
Editorial comment.
J Urol. 2009 Dec;182(6):2606. doi: 10.1016/j.juro.2009.08.197. Epub 2009 Oct 17.
8
Editorial comment.
Urology. 2010 Feb;75(2):281. doi: 10.1016/j.urology.2009.07.1323.
9
Editorial comment.
Urology. 2010 Feb;75(2):281. doi: 10.1016/j.urology.2009.07.1324.
10
The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy.
Nat Clin Pract Oncol. 2008 Dec;5(12):698-9. doi: 10.1038/ncponc1256. Epub 2008 Oct 14.
Zotero 插件